These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22996738)

  • 21. Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes.
    Corcoran C; Rani S; O'Brien K; O'Neill A; Prencipe M; Sheikh R; Webb G; McDermott R; Watson W; Crown J; O'Driscoll L
    PLoS One; 2012; 7(12):e50999. PubMed ID: 23251413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
    Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
    Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
    Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
    Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells.
    Shi GH; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Xiao WJ; Ma CG
    Acta Pharmacol Sin; 2010 Jul; 31(7):867-73. PubMed ID: 20581857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel.
    Rocha SM; Nascimento D; Coelho RS; Cardoso AM; Passarinha LA; Socorro S; Maia CJ
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.
    Watanabe H; Kawakami A; Sato R; Watanabe K; Matsushita Y; Miyake H
    Anticancer Res; 2021 Aug; 41(8):3753-3758. PubMed ID: 34281834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
    Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
    Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins.
    Edmondson R; Adcock AF; Yang L
    PLoS One; 2016; 11(6):e0158116. PubMed ID: 27352049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 30. [2-deoxyglucose enhances chemosensitivity of androgen-independent prostate cancer cells to docetaxel].
    Zhou P; Lin YR; Huang MP; Xie KJ; Tang P
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3230-4. PubMed ID: 24405548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term androgen ablation and docetaxel up-regulate phosphorylated Akt in castration resistant prostate cancer.
    Kosaka T; Miyajima A; Shirotake S; Suzuki E; Kikuchi E; Oya M
    J Urol; 2011 Jun; 185(6):2376-81. PubMed ID: 21511293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.
    Biernacka KM; Persad RA; Bahl A; Gillatt D; Holly JM; Perks CM
    Endocr Relat Cancer; 2017 Jan; 24(1):17-30. PubMed ID: 27754854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.
    Natsagdorj A; Izumi K; Hiratsuka K; Machioka K; Iwamoto H; Naito R; Makino T; Kadomoto S; Shigehara K; Kadono Y; Lin WJ; Maolake A; Mizokami A
    Cancer Sci; 2019 Jan; 110(1):279-288. PubMed ID: 30426599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.
    Ramachandran K; Gopisetty G; Gordian E; Navarro L; Hader C; Reis IM; Schulz WA; Singal R
    Cancer Res; 2009 Feb; 69(4):1527-35. PubMed ID: 19190346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
    Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
    Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.
    Mimeault M; Johansson SL; Vankatraman G; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
    Mol Cancer Ther; 2007 Mar; 6(3):967-78. PubMed ID: 17363490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of docetaxel on the regulation of proliferation and apoptosis of human prostate cancer cells.
    Yang C; Zhang W; Wang J; Chen P; Jin J
    Mol Med Rep; 2019 May; 19(5):3864-3870. PubMed ID: 30864701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
    Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
    Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer.
    Zhu Y; Liu C; Nadiminty N; Lou W; Tummala R; Evans CP; Gao AC
    Mol Cancer Ther; 2013 Sep; 12(9):1829-36. PubMed ID: 23861346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.